-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GlnuNM0glic+NwgZ2v3knRQcBDhJ34msPmV4NFoT0o5e/NIB3zJmDRdke6Rq98lL qXOdxZfotcIdjjkmx/pUsg== 0001127602-10-016670.txt : 20100607 0001127602-10-016670.hdr.sgml : 20100607 20100607200658 ACCESSION NUMBER: 0001127602-10-016670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100603 FILED AS OF DATE: 20100607 DATE AS OF CHANGE: 20100607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STEVENSON KATHARINE BERGHUIS CENTRAL INDEX KEY: 0001232227 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 10882698 MAIL ADDRESS: STREET 1: C/O NORTEL NETWORKS CORPORATION STREET 2: 8200 DIXIE ROAD STE 100 CITY: BRAMPTON ONTARIO STATE: A6 ZIP: L6T 5P6 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-06-03 0000729922 OSI PHARMACEUTICALS INC OSIP 0001232227 STEVENSON KATHARINE BERGHUIS C/O OSI PHARMACEUTICALS, INC. 420 SAW MILL RIVER RD. ARDSLEY NY 10502 1 Common Stock 11490 D Stock Option (Right to Buy) 47.34 2010-06-03 4 D 0 50000 57.50 D 2015-04-30 Common Stock 50000 0 D Stock Option (Right to Buy) 30.39 2010-06-03 4 D 0 3000 57.50 D 2013-06-13 Common Stock 3000 0 D Stock Option (Right to Buy) 36.25 2010-06-03 4 D 0 3000 57.50 D 2014-06-12 Common Stock 3000 0 D Stock Option (Right to Buy) 38.63 2010-06-03 4 D 0 7500 57.50 D 2015-06-10 Common Stock 7500 0 D Stock Option (Right to Buy) 28.65 2010-06-03 4 D 0 7500 57.50 D 2016-06-16 Common Stock 7500 0 D These stock options were canceled in exchange for a cash payment in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc. The cash payment made with respect to each stock option equals the product of (x) the number of shares issuable upon the exercise of such option multiplied by (y) the excess, if any, of $57.50 over the exercise price per share for such option. /s/ Pierre Legault, attorney-in-fact for Ms. Stevenson 2010-06-07 -----END PRIVACY-ENHANCED MESSAGE-----